Clinical trial
Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne
NCT00392223 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00392223 |
|---|---|
| Title | Efficacy And Safety Of Azithromycin SR Compared With Minocycline In Acne |
| Official title | A Phase III, Multicenter, Randomized, Double Blind-Double Dummy Study, To Evaluate Efficacy And Safety Of Treatment With Azithromycin, Microspheres, Oral Powder For Suspension, 2 G, In One Administration A Week, For 8 Weeks, Compared With Treatment With Minocycline Capsules, 100 Mg Die For 8 Weeks… |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acne Vulgaris |
| Intervention type | Drug |
| Interventions | Azithromycin microspheres, minocycline-placebo capsules, Azithromycin microspheres-placebo, Minocycline capsules |
| Enrollment | 118 |
| Start date | Oct 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Oct 25, 2006 |
| Last update posted | Jan 12, 2010 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: